Protective KIR-HLA interactions for HCV infection in intravenous drug users.
Zúñiga J, Romero V, Azocar J, Terreros D, Vargas-Rojas MI, Torres-García D, Jiménez-Alvarez L, Vargas-Alarcón G, Granados-Montiel J, Husain Z, Chung RT, Alper CA, Yunis EJ.
Zúñiga J, et al.
Mol Immunol. 2009 Aug;46(13):2723-7. doi: 10.1016/j.molimm.2009.05.014. Epub 2009 Jun 24.
Mol Immunol. 2009.
PMID: 19552960
Free PMC article.